These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18751751

  • 1. Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology.
    Taylor AW, Bruno RS, Traber MG.
    Lipids; 2008 Oct; 43(10):925-36. PubMed ID: 18751751
    [Abstract] [Full Text] [Related]

  • 2. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
    Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB.
    Free Radic Biol Med; 2003 Feb 15; 34(4):409-18. PubMed ID: 12566066
    [Abstract] [Full Text] [Related]

  • 3. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
    Morales CR, Terry ES, Zackert WE, Montine TJ, Morrow JD.
    Clin Chim Acta; 2001 Dec 15; 314(1-2):93-9. PubMed ID: 11718683
    [Abstract] [Full Text] [Related]

  • 4. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
    Davies SS, Zackert W, Luo Y, Cunningham CC, Frisard M, Roberts LJ.
    Anal Biochem; 2006 Jan 15; 348(2):185-91. PubMed ID: 16309621
    [Abstract] [Full Text] [Related]

  • 5. Tandem mass spectrometric quantification of 8-iso-prostaglandin F2alpha and its metabolite 2,3-dinor-5,6-dihydro-8-iso-prostaglandin F2alpha in human urine.
    Schwedhelm E, Tsikas D, Durand T, Gutzki FM, Guy A, Rossi JC, Frölich JC.
    J Chromatogr B Biomed Sci Appl; 2000 Jul 07; 744(1):99-112. PubMed ID: 10985571
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous quantification of F2-isoprostanes and prostaglandins in human urine by liquid chromatography tandem-mass spectrometry.
    Prasain JK, Arabshahi A, Taub PR, Sweeney S, Moore R, Sharer JD, Barnes S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan 15; 913-914():161-8. PubMed ID: 23314354
    [Abstract] [Full Text] [Related]

  • 7. Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS.
    Zhang B, Saku K.
    J Lipid Res; 2007 Mar 15; 48(3):733-44. PubMed ID: 17215547
    [Abstract] [Full Text] [Related]

  • 8. Divergence in urinary 8-iso-PGF(2alpha) (iPF(2alpha)-III, 15-F(2t)-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF(2alpha). Possible methodological, mechanistic and clinical implications.
    Tsikas D, Schwedhelm E, Suchy MT, Niemann J, Gutzki FM, Erpenbeck VJ, Hohlfeld JM, Surdacki A, Frölich JC.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep 05; 794(2):237-55. PubMed ID: 12954376
    [Abstract] [Full Text] [Related]

  • 9. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
    Dorjgochoo T, Gao YT, Chow WH, Shu XO, Yang G, Cai Q, Rothman N, Cai H, Li H, Deng X, Franke A, Roberts LJ, Milne G, Zheng W, Dai Q.
    Am J Clin Nutr; 2012 Aug 05; 96(2):405-14. PubMed ID: 22760572
    [Abstract] [Full Text] [Related]

  • 10. Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men.
    Helmersson J, Larsson A, Vessby B, Basu S.
    Atherosclerosis; 2005 Jul 05; 181(1):201-7. PubMed ID: 15939073
    [Abstract] [Full Text] [Related]

  • 11. Quantitation of plasma total 15-series F(2)-isoprostanes by sequential solid phase and liquid-liquid extraction.
    Taylor AW, Traber MG.
    Anal Biochem; 2010 Jan 15; 396(2):319-21. PubMed ID: 19788885
    [Abstract] [Full Text] [Related]

  • 12. Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
    Zhang H, Il'yasova D, Sztaray J, Young SP, Wang F, Millington DS.
    Anal Biochem; 2010 Apr 15; 399(2):302-4. PubMed ID: 20026293
    [Abstract] [Full Text] [Related]

  • 13. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.
    Yin H, Gao L, Tai HH, Murphey LJ, Porter NA, Morrow JD.
    J Biol Chem; 2007 Jan 05; 282(1):329-36. PubMed ID: 17107953
    [Abstract] [Full Text] [Related]

  • 14. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD, Zackert WE, Yang JP, Kurhts EH, Callewaert D, Dworski R, Kanai K, Taber D, Moore K, Oates JA, Roberts LJ.
    Anal Biochem; 1999 May 01; 269(2):326-31. PubMed ID: 10222005
    [Abstract] [Full Text] [Related]

  • 15. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
    Nourooz-Zadeh J, Cooper MB, Ziegler D, Betteridge DJ.
    Biochem Biophys Res Commun; 2005 May 13; 330(3):731-6. PubMed ID: 15809058
    [Abstract] [Full Text] [Related]

  • 16. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
    Dworski R, Roberts LJ, Murray JJ, Morrow JD, Hartert TV, Sheller JR.
    Clin Exp Allergy; 2001 Mar 13; 31(3):387-90. PubMed ID: 11260149
    [Abstract] [Full Text] [Related]

  • 17. Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography.
    Ritov VB, Kelley DE, Kagan VE.
    Anal Biochem; 2002 Dec 01; 311(1):10-8. PubMed ID: 12441147
    [Abstract] [Full Text] [Related]

  • 18. Determination of urinary 8-epi-prostaglandin F(2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics.
    Murai Y, Hishinuma T, Suzuki N, Satoh J, Toyota T, Mizugaki M.
    Prostaglandins Other Lipid Mediat; 2000 Jul 01; 62(2):173-81. PubMed ID: 10938411
    [Abstract] [Full Text] [Related]

  • 19. Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans.
    Roberts LJ, Moore KP, Zackert WE, Oates JA, Morrow JD.
    J Biol Chem; 1996 Aug 23; 271(34):20617-20. PubMed ID: 8702808
    [Abstract] [Full Text] [Related]

  • 20. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort.
    Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB, Wagenknecht LE.
    Obesity (Silver Spring); 2012 Sep 23; 20(9):1915-21. PubMed ID: 21959342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.